Goringe A P, Brown S, O'Callaghan U, Rees J, Jebb S, Elia M, Poynton C H
Department of Haematology, University Hospital of Wales, College of Medicine, Cardiff, UK.
Bone Marrow Transplant. 1998 Apr;21(8):829-32. doi: 10.1038/sj.bmt.1701172.
Hepatic veno-occlusive disease (VOD) of the liver is a common complication following high-dose cytotoxic therapy for bone marrow transplantation (BMT). Liver injury is believed to occur following free radical damage to endothelial cells of the sinusoids and small hepatic veins. Glutathione the main antioxidant of the cytosol becomes depleted following chemotherapy. Animal studies have shown that glutamine infusions can maintain glutathione levels and protect against free radical injury. We present two cases of established VOD successfully treated with intravenous glutamine (as dipeptide) and oral vitamin E. Although both cases have possible confounding factors we believe that these give support to the notion that glutamine/vitamin E may have a role in the prophylaxis and treatment of VOD. Further formal trials are indicated.
肝静脉闭塞病(VOD)是骨髓移植(BMT)大剂量细胞毒性治疗后的常见并发症。据信,肝损伤是在肝血窦和小肝静脉内皮细胞受到自由基损伤后发生的。化疗后,细胞溶质中的主要抗氧化剂谷胱甘肽会耗尽。动物研究表明,输注谷氨酰胺可以维持谷胱甘肽水平并预防自由基损伤。我们报告了两例确诊的VOD患者,通过静脉输注谷氨酰胺(作为二肽)和口服维生素E成功治愈。尽管这两例都可能存在混杂因素,但我们认为这些支持了谷氨酰胺/维生素E可能在VOD的预防和治疗中发挥作用的观点。需要进一步进行正式试验。